Omeros Corporation, an innovative biotechnology company, announced that the US Food and Drug Administration (FDA) has approved Yartemlea (narsoplimab-wuug) for the treatment of hematopoietic stem cell ...

The FDA has approved narsoplimab (Yartemlea) as the first treatment for hematopoietic stem cell transplant (HSCT)-associated thrombotic microangiopathy (TA-TMA) in adults and kids ages 2 years and up, ...

"We'll have a self-driving car by [insert ambitious year here]" seems to be a line written in all speeches given by all C-level executives for all manufacturers when addressing, well, all audiences.

Mercedes-Benz MBGn.DE said on Monday it will launch a new advanced driver-assistance system in the United States later this year that lets its vehicles operate autonomously on city streets under ...

Riding shotgun next to Lucas Bolster in a prototype Mercedes-Benz CLA-Class, I tried to keep up as he explained his company's artificial intelligence strategy. I was there to see how MB.Drive Assist ...